Otter Pharmaceuticals, LLC entered into an agreement to acquire certain worldwide assets used in the operation of the OTREXUP from Antares Pharma, Inc. (NasdaqCM:ATRS) for $44 million on December 15, 2021. As per the terms of the transaction, $18 million shall be paid at closing, $16 million, payable on May 31, 2022 and $10 million to be paid on December 15, 2022, the one-year anniversary of the closing date. Otter Pharmaceuticals, LLC completed the acquisition of certain worldwide assets used in the operation of the OTREXUP from Antares Pharma, Inc. (NasdaqCM:ATRS) on December 15, 2021.